NDST1 Preferred Promoter Confirmation and Identification of Corresponding Transcriptional Inhibitors as Substrate Reduction Agents for Multiple Mucopolysaccharidosis Disorders

PLoS ONE - United States
doi 10.1371/journal.pone.0162145
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Non-Peptidic Substrate-Mimetic Inhibitors of Akt as Potential Anti-Cancer Agents

Bioorganic and Medicinal Chemistry
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2009English

Kinase Inhibitors as Potential Agents in the Treatment of Multiple Myeloma

Oncotarget
Oncology
2016English

Identification and Characterization of Preferred DNA-binding Sites for the Thermus Thermophilus Transcriptional Regulator FadR

PLoS ONE
Multidisciplinary
2017English

Genetic Substrate Reduction Therapy: A Promising Approach for Lysosomal Storage Disorders

Diseases
2016English

Transcriptional Regulation of the Rat Apelin Receptor Gene: Promoter Cloning and Identification of an Sp1 Site Necessary for Promoter Activity

Journal of Molecular Endocrinology
EndocrinologyMolecular Biology
2006English

Disorders of Transcriptional Regulation: An Emerging Category of Multiple Malformation Syndromes

Molecular Syndromology
Genetics
2016English

Platinum-Based Inhibitors of Amyloid- As Therapeutic Agents for Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Drug Repositioning of Mevalonate Pathway Inhibitors as Antitumor Agents for Ovarian Cancer

Oncotarget
Oncology
2017English

A Study of Mycobacterial Transcriptional Apparatus: Identification of Novel Features in Promoter Elements.

Journal of Bacteriology
MicrobiologyMolecular Biology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy